1. Chondroitin sulfate supplementation improves clinical outcomes in a murine model of necrotizing enterocolitis
- Author
-
Krishna Manohar, Brian D. Hosfield, Fikir M. Mesfin, Cameron Colgate, William Christopher Shelley, Jianyun Liu, Lifan Zeng, John P. Brokaw, and Troy A. Markel
- Subjects
chondroitin sulfate ,eNOS ,intestinal dysbiosis ,necrotizing enterocolitis ,Physiology ,QP1-981 - Abstract
Abstract Necrotizing enterocolitis (NEC) continues to be a devastating disease in preterm neonates and has a paucity of medical management options. Chondroitin sulfate (CS) is a naturally occurring glycosaminoglycan (GAG) in human breast milk (HM) and has been shown to reduce inflammation. We hypothesized that supplementation with CS in an experimental NEC model would alter microbial diversity, favorably alter the cytokine profile, and (like other sulfur compounds) improve outcomes in experimental NEC via the eNOS pathway. NEC was induced in 5‐day‐old pups. Six groups were studied (n = 9–15/group): (1) WT breastfed and (2) Formula fed controls, (3) WT NEC, (4) WT NEC + CS, (5) eNOS KO (knockout) NEC, and (6) eNOS KO NEC + CS. Pups were monitored for clinical sickness score and weights. On postnatal day 9, the pups were killed. Stool was collected from rectum and microbiome analysis was done with 16 s rRNA sequencing. Intestinal segments were examined histologically using a well‐established injury scoring system and segments were homogenized and analyzed for cytokine profile. Data were analyzed using GraphPad Prism with p
- Published
- 2023
- Full Text
- View/download PDF